Table 4:
Treatment of Wilson's Disease
Drug
Dose and Route of
Administration
Penicillamine (Cupramine, Depen) 250 mg tid or qid p.o.
Trientine (Syprine) 250 mg tid or qid p.o.
Zinc salts
   sulfate, gluconate, or acetate
50 mg tid p.o. (as elemental zinc)
  1. In all therapies, the goal is to reduce serum free copper (non-ceruloplasmin bound) to less than 10 µg/dL
  2. Zinc salts may be substituted as a maintenance therapy after adequate decoppering has been achieved, but may be the treatment of choice in selected asymptomatic Wilson's disease patients
Copyright 2002 The Cleveland Clinic Foundation

Return to Wilson's Disease Chapter